refresh

热门公司

Trending

招聘

Jobs

CRISPR Therapeutics

CRISPR Therapeutics

CRISPR Therapeutics

Leading company in the technology industry

Gene Editing

Cell Therapy

Clinical Research

Bioinformatics

Molecular Biology

Cambridge, Massachusetts, United States

201-500

Founded 2013 (13yrs)

Hybrid

Public

Valuation

$2.9B

Total Funding

$500M

CRSP

$53.07

Revenue (2026)

$0

Operating Income

$0

Open Positions

9 positions

Executive Director, External Manufacturing & Supply Chain

South Boston, MA

On-site

Director

Full-time

$260,000 - $290,000

Equity

Equity

Senior Manager, Supply Chain

South Boston, MA

On-site

Lead

Full-time

$130,000 - $150,000

Equity

Equity

Associate Director, Global Regulatory Lead

South Boston, MA

On-site

Director

Full-time

$170,000 - $195,000

Healthcare

Equity

Director, Clinical Development AID

South Boston, MA

On-site

Director

Full-time

$190,000 - $220,000

Equity

Equity

Manager, Infusion Support Operations

South Boston, MA

On-site

Lead

Full-time

$118,000 - $130,000

Equity

Equity

Director, Clinical Development CVD

South Boston, MA

On-site

Director

Full-time

$190,000 - $220,000

Equity

Equity

Senior Scientist, LNP MSAT

South Boston, MA

On-site

Senior

Full-time

$137,000 - $150,000

Equity

Equity

Manufacturing Associate, LNP

Framingham, MA

On-site

Entry

Full-time

$72,800 - $87,360

Equity

Equity

Clinical Trial Associate (One-Year Contract)

South Boston, MA

On-site

Entry

Contract

$83,200 - $104,000

Products & Services

EX

Exagamglogene Autotemcel (exa-cel) for Sickle Cell Disease

Gene Therapy

EX

Exagamglogene Autotemcel (exa-cel) for β-thalassemia

Gene Therapy

Leadership

DA

Daniel Anderson

Scientific Founders

SK

Stephen Kennedy

Head Of Technical Operations

RP

Raju Prasad

Chief Financial Officer

PKM

Phuong Khanh Morrow

Chief Medical Officer

Total Views

0

Apply Clicks

0

Mock Applicants

0

Scraps

0

Reviews

3.8

1 reviews

Work Life Balance

3.5

Compensation

3.5

Culture

4.0

Career

4.5

Management

4.0

85%

Recommend to a Friend

Pros

Innovative biotech company with cutting-edge medicine

New standard of care in sickle cell disease

Large pipeline with significant growth potential

Cons

Uncertainty about healthcare system readiness for curative therapies

Market adoption challenges for one-time treatments

Regulatory and reimbursement uncertainties

Salary Ranges

64 data points

Mid/L4

Senior/L5

Mid/L4

1 reports

$143,000

total / year

Base

$110,000

Stock

-

$143,000

$143,000

Interview Experience

64 interviews

Difficulty

3.3

/ 5

Duration

2-5w

Offer Rate

37%

Experience

Positive 67%

Neutral 20%

Negative 13%

Interview Process

1

Phone Screen

2

Technical Interview

3

System Design

4

Behavioral

5

Team Fit

Contact & Location